Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Chimie Des Substances Naturelles Lab DefiledCriticalInst Nat Sante Rech Med
Priority to TNP2009000491ApriorityCriticalpatent/TN2009000491A1/en
Publication of TN2009000491A1publicationCriticalpatent/TN2009000491A1/en
The present invention relates to therapy of stem cell cancer and more specifically against acute myeloid leukaemia. The present invention more precisely deals with the use of heterosidic flavonoid derivatives and in particular rutin, or derivatives thereof for the treatment of stem cell cancer specifically acute myeloid leukaemia, for preventing tumor relapse in a patient and/or for preventing solid tumor metastasis in a patient.
TNP2009000491A2009-11-232009-11-23Use of heterosidic flavonoid derivatives for therapy of stem cell cancers
TN2009000491A1
(en)
Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy